The Trade Mission in the USA allows companies to access the world-leading ecosystem in genomic medicine and precision therapies, with a specialized agenda in innovation, clinical validation, and alliances with Boston’s advanced research centers. The experience includes meetings with laboratories, sequencing platforms, and key biotechnology actors oriented towards predictive models and biomarkers. Participating in this environment boosts technological transfer, identification of scientific partners, and development of pre-commercial pilots. The US market offers high demand for solutions accelerating molecular diagnosis and patient stratification.
